Loading...
•
Dec 31, 2022
Globus Medical Q4 2022 Earnings Report
Globus Medical's Q4 2022 results showed record sales and increased profitability.
Key Takeaways
Globus Medical reported a record-setting fourth quarter in 2022, achieving record total sales, U.S. Spine sales, and Enabling Technologies sales. Worldwide net sales increased by 9.8% to $274.5 million, with GAAP net income rising by 231.4% to $50.1 million. The company's diluted EPS was $0.49, and non-GAAP diluted EPS was $0.59.
Worldwide net sales increased by 9.8% to $274.5 million.
GAAP net income increased by 231.4% to $50.1 million.
Diluted EPS was $0.49 and non-GAAP diluted EPS was $0.59.
Non-GAAP adjusted EBITDA was $90.2 million, representing 32.8% of net sales.
Globus Medical
Globus Medical
Globus Medical Revenue by Segment
Globus Medical Revenue by Geographic Location
Revenue by Segment
Musculoskeletal Solutions Revenue
CapyFin.comEnabling Technologies Revenue
CapyFin.comRevenue by Geographic Location
United States Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
The Company announced full year stand-alone 2023 guidance with expected net sales of $1.1 billion and non-GAAP diluted earnings per share of $2.30.
Positive Outlook
- Expected net sales of $1.1 billion.
- Non-GAAP diluted earnings per share of $2.30.
Revenue & Expenses
Visualization of income flow from segment revenue to net income